{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T11:39:51Z","timestamp":1779881991160,"version":"3.53.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":5885,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1038\/labinvest.3700482","type":"journal-article","created":{"date-parts":[[2006,10,30]],"date-time":"2006-10-30T11:25:50Z","timestamp":1162207550000},"page":"1221-1232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":312,"title":["Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion"],"prefix":"10.1016","volume":"86","author":[{"given":"David","family":"Zagzag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yevgeniy","family":"Lukyanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Aktar","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mine","family":"Esencay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn B","family":"Voura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth W","family":"Newcomb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/labinvest.3700482_bib1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1750-3639.2005.tb00115.x","article-title":"Angiogenesis in gliomas: biology and molecular pathophysiology","volume":"15","author":"Fischer","year":"2005","journal-title":"Brain Pathol"},{"key":"10.1038\/labinvest.3700482_bib2","first-page":"1408","article-title":"The unique physiology of solid tumors: opportunities (and problems) for cancer therapy","volume":"58","author":"Brown","year":"1998","journal-title":"Cancer Res"},{"key":"10.1038\/labinvest.3700482_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0092-8674(00)80176-2","article-title":"The hypoxic response: Huffing and HIFing","volume":"89","author":"Guillemin","year":"1997","journal-title":"Cell"},{"key":"10.1038\/labinvest.3700482_bib4","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1146\/annurev.cellbio.15.1.551","article-title":"Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1","volume":"15","author":"Semenza","year":"1999","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1038\/labinvest.3700482_bib5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/er.2003-0027","article-title":"Vascular endothelial growth factor: basic science and clinical progress","volume":"25","author":"Ferrara","year":"2004","journal-title":"Endocr Rev"},{"key":"10.1038\/labinvest.3700482_bib6","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/28867","article-title":"Role of HIF-1\u03b1 in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis","volume":"394","author":"Carmeliet","year":"1998","journal-title":"Nature"},{"key":"10.1038\/labinvest.3700482_bib7","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1128\/MCB.16.9.4604","article-title":"Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1","volume":"6","author":"Forsythe","year":"1996","journal-title":"Mol Cell Biol"},{"key":"10.1038\/labinvest.3700482_bib8","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/labinvest.3700482_bib9","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nrd1199","article-title":"HIF-1 as a target for drug development","volume":"2","author":"Giaccia","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1038\/labinvest.3700482_bib10","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1158\/1535-7163.647.3.5","article-title":"Hypoxia inducible factor-1\u03b1 as a cancer drug target","volume":"3","author":"Powis","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"10.1038\/labinvest.3700482_bib11","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrc1367","article-title":"Exploiting tumour hypoxia in cancer treatment","volume":"4","author":"Brown","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/labinvest.3700482_bib12","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4161\/cc.3.2.688","article-title":"Targeting topoisomerase I to inhibit hypoxia inducbile factor 1","volume":"3","author":"Rapisarda","year":"2004","journal-title":"Cell Cycle"},{"key":"10.1038\/labinvest.3700482_bib13","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.bcp.2004.02.040","article-title":"New anticancer strategies targeting HIF-1","volume":"68","author":"Yeo","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1038\/labinvest.3700482_bib14","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/sj.ki.5000065","article-title":"Kidney cancer: identification of novel targets for therapy","volume":"69","author":"Weiss","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/labinvest.3700482_bib15","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1002\/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W","article-title":"Expression of hypoxia-inducible factor 1\u03b1 in brain tumors: association with angiogenesis, invasion, and progression","volume":"88","author":"Zagzag","year":"2000","journal-title":"Cancer"},{"key":"10.1038\/labinvest.3700482_bib16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/1097-0142(20010701)92:1<165::AID-CNCR1305>3.0.CO;2-F","article-title":"Expression of hypoxia-inducible factor-1\u03b1 in oligodendrogliomas: its impact on prognosis and on neoangiogenesis","volume":"92","author":"Birner","year":"2001","journal-title":"Cancer"},{"key":"10.1038\/labinvest.3700482_bib17","first-page":"5830","article-title":"Overexpression of hypoxia-inducible factor 1\u03b1 in common human cancers and their metastases","volume":"59","author":"Zhong","year":"1999","journal-title":"Cancer Res"},{"key":"10.1038\/labinvest.3700482_bib18","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1158\/1078-0432.CCR-04-1685","article-title":"Expression of hypoxia-inducible factor-1\u03b1 protein predicts survival in patients with transitional cell carcinoma of the upper urinary tract","volume":"11","author":"Nakanishi","year":"2005","journal-title":"Clin Can Res"},{"key":"10.1038\/labinvest.3700482_bib19","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/jcp.2004.019885","article-title":"Differential prognostic impact of hypoxia induced and diffuse HIF-1\u03b1 expression in invasive breast cancer","volume":"58","author":"Vleugel","year":"2005","journal-title":"J Clin Pathol"},{"key":"10.1038\/labinvest.3700482_bib20","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/359843a0","article-title":"Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis","volume":"359","author":"Shweiki","year":"1992","journal-title":"Nature"},{"key":"10.1038\/labinvest.3700482_bib21","first-page":"3860","article-title":"Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia driven mechanisms","volume":"57","author":"Damert","year":"1997","journal-title":"Cancer Res"},{"key":"10.1038\/labinvest.3700482_bib22","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature01874","article-title":"Chemokine receptor CXCR4 downregulated by von Hippel\u2013Lindau tumour suppressor pVHL","volume":"425","author":"Staller","year":"2003","journal-title":"Nature"},{"key":"10.1038\/labinvest.3700482_bib23","doi-asserted-by":"crossref","first-page":"6178","DOI":"10.1158\/0008-5472.CAN-04-4406","article-title":"Stromal cell-derived factor-1\u03b1 and CXCR4 expression in hemangioblastoma and clear cell\u2013renal cell Carcinoma: von Hippel\u2013Lindau loss-of-function induces expression of a ligand and its receptor","volume":"65","author":"Zagzag","year":"2005","journal-title":"Cancer Res"},{"key":"10.1038\/labinvest.3700482_bib24","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/(SICI)1098-1004(1998)12:6<424::AID-HUMU9>3.0.CO;2-H","article-title":"Germline mutation profile of the VHL gene in von Hippel\u2013Lindau disease and in sporadic hemangioblastoma","volume":"12","author":"Olschwang","year":"1998","journal-title":"Hum Mutat"},{"key":"10.1038\/labinvest.3700482_bib25","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/382829a0","article-title":"The lymphocyte chemoattractant SDF-1 is a ligand for LESTR\/fusin and blocks HIV-1 entry","volume":"382","author":"Bleul","year":"1996","journal-title":"Nature"},{"key":"10.1038\/labinvest.3700482_bib26","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1182\/blood-2005-08-3182","article-title":"CXCR4: a key receptor in the cross talk between tumor cells and their microenvironment","volume":"107","author":"Burger","year":"2006","journal-title":"Blood"},{"key":"10.1038\/labinvest.3700482_bib27","doi-asserted-by":"crossref","first-page":"8273","DOI":"10.1158\/1078-0432.CCR-05-0537","article-title":"Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells","volume":"11","author":"Su","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1038\/labinvest.3700482_bib28","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1053\/j.gastro.2005.06.056","article-title":"CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer","volume":"129","author":"Saur","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1038\/labinvest.3700482_bib29","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.breast.2004.12.007","article-title":"The elevated level of CXCR4 is correlated with nodal metastasis of human breast cancer","volume":"14","author":"Kang","year":"2005","journal-title":"Breast"},{"key":"10.1038\/labinvest.3700482_bib30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10585-005-3222-y","article-title":"Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow","volume":"22","author":"Cabioglu","year":"2005","journal-title":"Clin Exp Metast"},{"key":"10.1038\/labinvest.3700482_bib31","first-page":"102","article-title":"Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma","volume":"6","author":"Rempel","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1038\/labinvest.3700482_bib32","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.4049\/jimmunol.166.4.2695","article-title":"CXC chemokine receptor 4 expression and function in human astroglioma cells","volume":"166","author":"Oh","year":"2001","journal-title":"J Immunol"},{"key":"10.1038\/labinvest.3700482_bib33","doi-asserted-by":"crossref","first-page":"49481","DOI":"10.1074\/jbc.M206222200","article-title":"CXCR4 is a major chemokine receptor on glioma cells and mediates their survival","volume":"277","author":"Zhou","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.3700482_bib34","doi-asserted-by":"crossref","first-page":"11392","DOI":"10.1158\/0008-5472.CAN-05-0847","article-title":"Widespread CXCR4 activation in astrocytomas revealed by phospho-CXCR4-specific antibodies","volume":"65","author":"Woerner","year":"2005","journal-title":"Cancer Res"},{"key":"10.1038\/labinvest.3700482_bib35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.canlet.2005.05.011","article-title":"SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion","volume":"236","author":"Hong","year":"2006","journal-title":"Cancer Lett"},{"key":"10.1038\/labinvest.3700482_bib36","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1038\/sj.onc.1209302","article-title":"CXCR4 expression mediates glioma cell invasiveness","volume":"25","author":"Ehtesham","year":"2006","journal-title":"Oncogene"},{"key":"10.1038\/labinvest.3700482_bib37","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/jnen\/61.3.215","article-title":"The WHO classification of tumors of the nervous system","volume":"61","author":"Kleihues","year":"2002","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1038\/labinvest.3700482_bib38","doi-asserted-by":"crossref","first-page":"14153","DOI":"10.1074\/jbc.M010429200","article-title":"Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor","volume":"276","author":"Gerlach","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.3700482_bib39","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/gut.48.1.87","article-title":"Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinoma","volume":"48","author":"von Marschall","year":"2001","journal-title":"Gut"},{"key":"10.1038\/labinvest.3700482_bib40","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1210\/en.2005-1638","article-title":"Lentiviral short hairpin ribonucleic acid-mediated knockdown of GLUT4 in 3T3-L1 adipocytes","volume":"147","author":"Liao","year":"2006","journal-title":"Endocrinonology"},{"key":"10.1038\/labinvest.3700482_bib41","first-page":"2660","article-title":"Tenascin-C promotes microvascular cell migration and phosphorylation of focal adhesion kinase","volume":"62","author":"Zagzag","year":"2002","journal-title":"Cancer Res"},{"key":"10.1038\/labinvest.3700482_bib42","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1084\/jem.20030267","article-title":"Regulation of the chemokine receptor CXCR4 by hypoxia","volume":"198","author":"Schioppa","year":"2003","journal-title":"J Exp Med"},{"key":"10.1038\/labinvest.3700482_bib43","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/425247a","article-title":"Cues for migration","volume":"425","author":"Bernards","year":"2003","journal-title":"Nature"},{"key":"10.1038\/labinvest.3700482_bib44","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1158\/0008-5472.465.65.2","article-title":"CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers","volume":"65","author":"Kryczek","year":"2005","journal-title":"Cancer Res"},{"key":"10.1038\/labinvest.3700482_bib45","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2337\/diabetes.48.5.1131","article-title":"Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells","volume":"48","author":"Marumo","year":"1999","journal-title":"Diabetes"},{"key":"10.1038\/labinvest.3700482_bib46","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0002-9440(10)65365-5","article-title":"Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: in vivo neovascularization induced by stromal-derived factor-1alpha","volume":"154","author":"Salcedo","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1038\/labinvest.3700482_bib47","doi-asserted-by":"crossref","first-page":"10445","DOI":"10.1074\/jbc.M107348200","article-title":"Vascular endothelial growth factor modulates neutrophil transendothelial migration via up-regulation of interleukin-8 in human brain microvascular endothelial cells","volume":"277","author":"Lee","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.3700482_bib48","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1215\/S1152851705000050","article-title":"Scatter factor\/hepatocyte growth factor in brain tumor growth and angiogenesis","volume":"7","author":"Abounader","year":"2005","journal-title":"Neuro-oncol"},{"key":"10.1038\/labinvest.3700482_bib49","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.yexcr.2005.07.008","article-title":"Hepatocyte growth factor enhances CXCR4 expression favoring breast cancer cell invasiveness","volume":"310","author":"Matteucci","year":"2005","journal-title":"Exp Cell Res"},{"key":"10.1038\/labinvest.3700482_bib50","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/31261","article-title":"The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract","volume":"393","author":"Tachibana","year":"1998","journal-title":"Nature"},{"key":"10.1038\/labinvest.3700482_bib51","doi-asserted-by":"crossref","first-page":"5864","DOI":"10.1158\/0008-5472.CAN-04-3833","article-title":"Blockade of the stromal cell-derived factor-1\/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner","volume":"65","author":"Guleng","year":"2005","journal-title":"Cancer Res"},{"key":"10.1038\/labinvest.3700482_bib52","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1006\/bbrc.1997.7890","article-title":"Chemokine receptor CXCR4 expression in endothelium","volume":"242","author":"Volin","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/labinvest.3700482_bib53","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0049-3848(00)00292-9","article-title":"SDF-1 activity on microvascular endothelial cells: consequences on angiogenesis in in vitro in vivo models","volume":"99","author":"Mirshahi","year":"2000","journal-title":"Thromb Res"},{"key":"10.1038\/labinvest.3700482_bib54","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.mcp.2003.07.007","article-title":"The use of suppression subtractive hybridization for the study of SDF-1alpha induced gene-expression in human endothelial cells","volume":"5","author":"Neuhaus","year":"2003","journal-title":"Mol Cell Probes"},{"key":"10.1038\/labinvest.3700482_bib55","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/nm1075","article-title":"Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1","volume":"10","author":"Ceradini","year":"2004","journal-title":"Nat Med"},{"key":"10.1038\/labinvest.3700482_bib56","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.semcancer.2003.10.006","article-title":"CXC chemokines in angiogenesis of cancer","volume":"4","author":"Strieter","year":"2004","journal-title":"Semin Cancer Biol"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/3700482.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/3700482","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722017548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722017548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/3700482.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:41:56Z","timestamp":1758397316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722017548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":56,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S0023683722017548"],"URL":"https:\/\/doi.org\/10.1038\/labinvest.3700482","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/labinvest.3700482","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2006 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}